BLOOD PRESSURE (BP) GOAL NNT CVA or MI2 = 36 ≤ 139 / 89 mm Hg – All Adult Hypertension
Pregnancy Potential: Avoid ACE-Inhibitors1
Add amlodipine 5 mg X ½ daily 5 mg X 1 daily 10 mg daily
SPIRONOLACTONE OR BETA-BLOCKER IF on thiazide AND eGFR ≥ 60 mL/min/1.73m2 AND K < 4.5
Add spironolactone 12.5 mg daily 25 mg daily
Add atenolol 25 mg daily 50 mg daily (Keep heart rate > 55)
• Consider medication non-adherence. • Consider interfering agents (e.g., NSAIDs, excess alcohol). • Consider white coat effect. Consider BP checks by medical assistant
(e.g., two checks with 2 readings each, 1 week apart).
• Consider discontinuing lisinopril / HCTZ and changing to chlorthalidone 25 mg plus lisinopril
40 mg daily. Consider additional agents (hydralazine, terazosin, reserpine, minoxidil).
• Consider stopping atenolol and adding diltiazem to amlodipine, keeping heart rate > 55. • Avoid using clonidine, verapamil, or diltiazem together with a beta blocker. These heart-rate slowing drug combinations may cause symptomatic bradycardia over time.
• Consider secondary etiologies. • Consider consultation with a hypertension specialist.
1. ACE-Inhibitors are contraindicated in pregnancy and not recommended in most child-bearing age women.
2. NNT = number needed to treat to prevent one event, maintaining hypertension control for at least 5 years. 2013 Kaiser Permanente Medical Care Program. Used with per
Organizations ma manente Medical Care Program
Medication up-titrations are recommended at 2-4 week intervals (for most patients) until control is achieved.
Consider follow-up labs when up-titrating or adding lisinopril/HCTZ, chlorthalidone, HCTZ, or spironolactione.
Use lipid lowering therapy according to Dyslipidemia Management in Adults guideline:
http://cl.kp.org/pkc/national/cmi/programs/dyslipidemia/guideline/index.html
If pregnant, refer to OB/GYN for hypertension management. If on ACE-Is or ARBs, discontinue immediately. LIFESTYLE CHANGES ARE RECOMMENDED FOR ALL PATIENTS:
Sodium restriction (≤ 2.4 gm sodium daily).
Weight reduction if BMI ≥ 25 kg/m2.
Exercise at a moderate pace to achieve 150 mins / week (i.e., 30 min / 5 days/wk).
Limit daily alcohol to no more than 1 drink (women) or 2 drinks (men).
Smoking cessation is strongly recommended; counsel tobacco users on the health risks of smoking,
RECOMMENDATIONS FOR PATIENTS WITH ACE-I INTOLERANCE:
1. HCTZ 25 mg, then 50 mg to achieve BP goal. 2. Add losartan 25 mg, then 50 mg, then 100 mg to achieve BP goal. 3. Add amlodopine 2.5 mg, then 5 mg, then 10 mg to achieve BP goal. Table 2: Dosage Range for Selected Antihypertensive Medications1 DRUG CLASS GENERIC (OTHER NAMES) USUAL DOSAGE RANGE ACE-I-THIAZIDE COMBINATION PILL THIAZIDE-TYPE DIURETICS THIAZIDE-TYPE DIURETICS THIAZIDE-TYPE DIURETICS ACE INHIBITORS (ACE-I) ACE INHIBITORS (ACE-I) ACE INHIBITORS (ACE-I) ANGIOTENSIN II RECEPTOR BLOCKER (ARB) LONG-ACTING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS (CCB) LONG-ACTING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS (CCB) LONG-ACTING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS (CCB) ALDOSTERONE RECEPTOR BLOCKER BETA-BLOCKERS (BB) BETA-BLOCKERS (BB) BETA-BLOCKERS (BB) BETA-BLOCKERS (BB) ACE-I-THIAZIDE COMBINATION PILL ALPHA BLOCKERS ALPHA BLOCKERS ALPHA BLOCKERS DIRECT VASODILATORS DIRECT VASODILATORS ALPHA-2 AGONISTS PERIPHERAL ADRENERGIC INHIBITOR
1 Availability of medications may vary depending on regional formularies.
2013 Kaiser Permanente Medical Care Program. Used with per
Organizations ma manente Medical Care Program
The Book of Modules: A Chinese Herbal Formula Workbook, Cormac Ferguson, Cormac Ferguson, 2010, , . . The Tao of Nutrition , Maoshing Ni, Cathy McNease, 2009, Cooking, 255 pages. The Tao of Nutritionprovides information on making every meal therapeutic, teaching you how to make appropriate food choicesfor your ailments, your constitution, and the . The Tao of Fertility , Daoshing Ni, Dana Herk
ATLA 35 , 641–659, 2007 641 Systematic Reviews of Animal Experiments DemonstratePoor Human Clinical and Toxicological Utility Animal Consultants International, London, UK Summary — The assumption that animal models are reasonably predictive of human outcomes provides the basis for their widespread use in toxicity testing and in biomedical research aimed at developing cures for human dise